Healthy Ventures is on record against 20 companies.
This thesis invests at early-stage through Series B, targeting healthcare infrastructure verticals like payments, clinical trials, and data architecture. They are U.S.-focused, offering hands-on commercialization support for technical founders scaling into payer and provider markets.